Hormone Receptor-Positive Breast Cancer Sensitive to Pembrolizumab: Evidence of the Pathogenicity of the MLH1 Variant 1835del3.
Article in Journal of the National Comprehensive Cancer Network (August 2023)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Article in Journal of the National Comprehensive Cancer Network (August 2023)
Article in Cancers (August 2023)
Article in Cancers (August 2023)